Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis-Reference-Cited by-同舟云学术

Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis

Published:2021-11-03 Issue:22 Volume:134 Page:2700-2709
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Guo Cheng-Lin,Mei Jian-Dong,Jia Yu-Long,Gan Fan-Yi,Tang Yu-Dong,Liu Cheng-Wu,Zeng Zhen,Yang Zhen-Yu,Deng Sen-Yi,Sun Xing,Liu Lun-Xu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008

3. Immunotherapy in patients with early stage resectable nonsmall cell lung cancer;Ghysen;Curr Opin Oncol,2019

4. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

5. Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates;Sambi;J Oncol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic drug discovery: a case for thymosin alpha-1;Frontiers in Medicine;2024-06-06

2. Effect of thymalfasin on myeloid-derived suppressor cells in patients with non-small cell lung cancer;American Journal of Translational Research;2024

3. Mechanism and clinical application of thymosin in the treatment of lung cancer;Frontiers in Immunology;2023-08-28

4. Thymus-derived hormonal and cellular control of cancer;Frontiers in Endocrinology;2023-07-17